PROCEPT BioRobotics/$PRCT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About PROCEPT BioRobotics
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Ticker
$PRCT
Sector
Primary listing
Employees
888
Headquarters
Website
PRCT Metrics
BasicAdvanced
$950m
-
-$1.83
0.85
-
Price and volume
Market cap
$950m
Beta
0.85
52-week high
$58.87
52-week low
$16.67
Average daily volume
1.8m
Financial strength
Current ratio
6.726
Quick ratio
5.375
Long term debt to equity
21.756
Total debt to equity
22.434
Interest coverage (TTM)
-30.91%
Profitability
EBITDA (TTM)
-102.377
Gross margin (TTM)
63.97%
Net profit margin (TTM)
-31.82%
Operating margin (TTM)
-33.86%
Effective tax rate (TTM)
-0.19%
Revenue per employee (TTM)
$360,000
Management effectiveness
Return on assets (TTM)
-13.54%
Return on equity (TTM)
-27.81%
Valuation
Price to revenue (TTM)
2.899
Price to book
2.71
Price to tangible book (TTM)
2.74
Price to free cash flow (TTM)
-11.589
Free cash flow yield (TTM)
-8.63%
Free cash flow per share (TTM)
-1.44
Growth
Revenue change (TTM)
29.26%
Earnings per share change (TTM)
7.85%
3-year revenue growth (CAGR)
55.76%
3-year earnings per share growth (CAGR)
-5.96%
What the Analysts think about PRCT
Analyst ratings (Buy, Hold, Sell) for PROCEPT BioRobotics stock.
PRCT Financial Performance
Revenues and expenses
PRCT Earnings Performance
Company profitability
PRCT News
AllArticlesVideos
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with the Schall Law Firm
Business Wire·11 hours ago
PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Who Suffered Losses May Be Eligible to Participate in Securities Class Action; Contact Robbins LLP for Information About Recovering Your Losses
Business Wire·2 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.